Romo CG - Search Results

1

Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1.

Jiang C, McKay RM, Lee SY, Romo CG, Blakeley JO, Haniffa M, Serra E, Steensma MR, Largaespada D, Le LQ. Jiang C, et al. Among authors: romo cg. J Invest Dermatol. 2023 Aug;143(8):1369-1377. doi: 10.1016/j.jid.2022.12.027. Epub 2023 Jun 15. J Invest Dermatol. 2023. PMID: 37318402 Review.

2

cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults.

Fertitta L, Sarin KY, Bergqvist C, Patel E, Peiffer B, Moryousef S, Armand ML, Jannic A, Ferkal S, Ravaud P, Tran VT, Blakeley JO, Romo CG, Ezzedine K, Wolkenstein P. Fertitta L, et al. Among authors: romo cg. J Invest Dermatol. 2023 Nov;143(11):2226-2232.e1. doi: 10.1016/j.jid.2023.04.014. Epub 2023 May 5. J Invest Dermatol. 2023. PMID: 37149083

3

RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights.

Rhodes SD, McCormick F, Cagan RL, Bakker A, Staedtke V, Ly I, Steensma MR, Lee SY, Romo CG, Blakeley JO, Sarin KY. Rhodes SD, et al. Among authors: romo cg. J Invest Dermatol. 2023 Aug;143(8):1358-1368. doi: 10.1016/j.jid.2023.01.043. Epub 2023 May 27. J Invest Dermatol. 2023. PMID: 37245145 Review.

4

Target Product Profile for Cutaneous Neurofibromas: Clinical Trials to Prevent, Arrest, or Regress Cutaneous Neurofibromas.

Ly I, Romo CG, Gottesman S, Kelly KM, Kornacki D, York Z, Lee SY, Rhodes SD, Staedtke V, Steensma MR, Blakeley JO, Wolkenstein P. Ly I, et al. Among authors: romo cg. J Invest Dermatol. 2023 Aug;143(8):1388-1396. doi: 10.1016/j.jid.2023.01.041. Epub 2023 Jun 8. J Invest Dermatol. 2023. PMID: 37294242 Review.

5

Current and Emerging Imaging Techniques for Neurofibromatosis Type 1-Associated Cutaneous Neurofibromas.

Li Y, Blakeley JO, Ly I, Berman Y, Lau J, Wolkenstein P, Bergqvist C, Jia W, Milner TE, Katta N, Durkin AJ, Kennedy GT, Rowland R, Romo CG, Fleming J, Kelly KM. Li Y, et al. Among authors: romo cg. J Invest Dermatol. 2023 Aug;143(8):1397-1405. doi: 10.1016/j.jid.2023.03.1681. Epub 2023 Jun 17. J Invest Dermatol. 2023. PMID: 37330718 Review.

6

Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas.

Staedtke V, Topilko P, Le LQ, Grimes K, Largaespada DA, Cagan RL, Steensma MR, Stemmer-Rachamimov A, Blakeley JO, Rhodes SD, Ly I, Romo CG, Lee SY, Serra E. Staedtke V, et al. Among authors: romo cg. J Invest Dermatol. 2023 Aug;143(8):1378-1387. doi: 10.1016/j.jid.2023.01.042. Epub 2023 Jun 15. J Invest Dermatol. 2023. PMID: 37330719 Review.

7

A Call for Discovery and Therapeutic Development for Cutaneous Neurofibromas.

Blakeley JO, Le LQ, Lee SY, Ly I, Rhodes SD, Romo CG, Sarin KY, Staedtke V, Steensma MR, Wolkenstein P; 2022 NTAP Cutaneous Neurofibroma Symposium Participants. Blakeley JO, et al. Among authors: romo cg. J Invest Dermatol. 2023 Aug;143(8):1351-1357. doi: 10.1016/j.jid.2022.11.027. Epub 2023 Jun 21. J Invest Dermatol. 2023. PMID: 37354152 No abstract available.

8

Multidisciplinary neurofibromatosis conference in the management of patients with neurofibromatosis type 1 and schwannomatosis in a single tertiary care institution.

Debs P, Belzberg A, Blakeley J, Fayad L, Langmead S, Little E, Romo C, Schatz K, Slobogean B, Ahlawat S. Debs P, et al. Skeletal Radiol. 2024 May;53(5):909-916. doi: 10.1007/s00256-023-04511-4. Epub 2023 Nov 11. Skeletal Radiol. 2024. PMID: 37950060

9

Whole body MRI with DWI in people with NF1 and Schwannomatosis: Are qualitative and quantitative imaging features of peripheral lesions comparable to localized MRI?

Debs P, Fayad LM, Romo CG, Ahlawat S. Debs P, et al. Among authors: romo cg. Eur J Radiol. 2023 May;162:110802. doi: 10.1016/j.ejrad.2023.110802. Epub 2023 Mar 26. Eur J Radiol. 2023. PMID: 37001256

10

Toward risk stratification and personalized therapy for neurofibromas in neurofibromatosis type 1.

Romo CG, Sarin KY, Blakeley JO. Romo CG, et al. Br J Dermatol. 2024 Jan 23;190(2):145-146. doi: 10.1093/bjd/ljad452. Br J Dermatol. 2024. PMID: 38123358 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page